
Opinion|Videos|March 27, 2025
Optimizing ADC Supportive Care Prescribing and AE Management With Institutional Workflows
Panelists discuss how health care professionals use standardized antibody-drug conjugate (ADC) pathways to guide dosing, adverse effect (AE) management, and transitions. Protocols ensure monitoring, toxicity mitigation, and seamless shifts between therapies for optimal care.
Advertisement
Episodes in this series

Video content above has been prompted by the following:
- How does your institution incorporate treatment pathways or workflows to guide decision-making, dosing, AE management/monitoring, and patient transitions between different ADCs?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Implementing Enfortumab Vedotin-ejfv Plus Pembrolizumab: Navigating Safety Data and the Pharmacist’s Role
2
Key Data, Interviews at the 2025 ASH Annual Meeting and Exposition
3
Long-Term BENEFIT Data Affirm Isa-VRd as Standard of Care in Transplant-Ineligible NDMM
4
Improving Outcomes in Diffuse B-Cell Lymphoma Requires Multidisciplinary Evolution
5

















































































































































































































